New Zealand has become the latest country to approve the use of psilocybin, a hallucinogen in magic mushrooms, for therapeutic purposes, particularly for treatment-resistant depression. This policy change allows a psychiatrist to prescribe psilocybin under strict guidelines, marking a significant step in mental health treatment. Associate Minister for Health David Seymour expressed hope that more psychiatrists would seek to prescribe it. Other countries, including Australia and Switzerland, also recognize psilocybin's medicinal potential, revealing a growing trend toward integrating alternative treatments in mental health care.
David Seymour, New Zealand's Associate Minister for Health, highlighted the new policy for psilocybin as a significant advancement in treatment for those with resistant depression.
While psilocybin is federally viewed as having no accepted medical use in the U.S., several countries are moving towards implementing it for therapeutic purposes.
Collection
[
|
...
]